
    
      Patients will participate in two arms of the trial, one in which morphine will be
      administered transdermally, and, after a 3 day wash out period, one in which morphine will be
      administered subcutaneously. Blood draws will be done after both dosing methods in order to
      compare blood levels of morphine by the different routes.
    
  